Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel PhenotypeÀlvar Agustí, William MacNee, Ruth Tal‐Singer et al.|PLoS ONE|2012Cited by 849
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisKenneth L. Clark, Mark R. Edbrooke, Stephen Hughes et al.|Molecular Therapy — Nucleic Acids|2013Cited by 37